Coronary interventions

Stents and scaffolds

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment.

Filters

Search by author

Filter by type

Showing 1-20 of 242 articles

Coronary interventions

RENASCENT II: First in Human Evaluation of a Novel Sirolimus-Eluting Ultra-High Molecular Weight APTITUDE® Bioresorbable Scaffold: 9-and 24-Months Imaging and Clinical Results

Chieffo A, Khawaja SA, Latib A, Vesga B, Moncada M, Delgado JA, Fonseca J, Testa L, Esposito G, Ferrone M, Cortese B, Maehara A, Granada J, Colombo A, Montorfano M, Hernandez H, Arana C, Dager A, Bedogni F, Stabile E, De Benedictis M, Meliga E, Tarantini G, Antoniucci D, La Manna A, Tamburino C

March 10, 2020 | 10.4244/EIJ-D-19-00600

Coronary interventions

Absorb Bioresorbable Vascular Scaffold is Associated with Low Wall Shear Stress Compared to Xience V: A Biomechanical Analysis of the Absorb III Imaging Study.

Kumar A, Gogas B, Thompson EW, Burnett GM, Molony D, Hosseini H, Chandran K, Lefieux A, Honda Y, Lee J, Serruys P, Kereiakes DJ, Stone GW, Samady H, Raad M, Gupta S, Sternheim DG, Okada K, Rapoza RJ, Simonton C, Giddens DP, Veneziani A, King III S, Ellis SG

February 23, 2020 | 10.4244/EIJ-D-19-01128

Coronary interventions

Validation of Bleeding Risk Criteria (ARC-HBR) in Patients Undergoing Percutaneous Coronary Intervention and Comparison with Contemporary Bleeding Risk Scores

Ueki Y, Bär S, Losdat S, Otsuka T, Zanchin C, Zanchin T, Gragnano F, Gargiulo G, Siontis G, Praz F, Lanz J, Hunziker L, Stortecky S, Pilgrim T, Heg D, Valgimigli M, Windecker S, Räber L

February 18, 2020 | 10.4244/EIJ-D-20-00052

Coronary interventions

Biodegradable Polymer- versus Durable Polymer-Coated Sirolimus-Eluting Stents: The Final 5-Year Outcomes of the I-LOVE-IT 2 Trial

Xu K, Xu B, Guan C, Jing Q, Zheng Q, Li X, Zhao X, Wang H, Zhao X, Li Y, Li J, Yang Y, Han Y, Li X, Yu P, Zang H, Wang Z, Cao X, Zhang J, Pang W

February 11, 2020 | 10.4244/EIJ-D-19-00865

Coronary interventions

Dual antiplatelet therapy strategies and clinical outcomes in patients treated with polymer-free biolimus A9-coated stents

D'Ascenzo F, Gallone G, Boccuzzi G, Cortese B, Di Biasi M, Capodanno D, Vicinelli P, Infantino V, Poli A, Grigis G, Varbella F, De Ferrari G, Ielasi A

February 7, 2020 | 10.4244/EIJ-D-19-00450

Coronary interventions

Clinical outcomes of bioabsorbable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: two-year follow-up of the DESSOLVE III trial

Katagiri Y, Onuma Y, Lurz P, Buszman P, Piek J, Wykrzykowska J, Asano T, Kogame N, Takahashi K, Chang C, de Winter R, Serruys P, Wijns W

February 7, 2020 | 10.4244/EIJ-D-18-00944

Coronary interventions

Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial

Haude M, Ince H, Toelg R, Lemos P, von Birgelen C, Christiansen E, Wijns W, Neumann F, Eeckhout E, Garcia-Garcia H, Waksman R

February 7, 2020 | 10.4244/EIJ-D-18-01000

Coronary interventions

Twelve-month outcomes of 400 patients treated with a resorbable metal scaffold: insights from the BIOSOLVE-IV registry

Verheye S, Wlodarczak A, Montorsi P, Bennett J, Torzewski J, Haude M, Vrolix M, Buck T, Aminian A, van der Schaaf R, Nuruddin A, Lee M

February 7, 2020 | 10.4244/EIJ-D-18-01058

Coronary interventions

The Application of Predefined Optimization Criteria for Intravascular Ultrasound Guidance of Left Main Stenting Improves Outcomes.

de la Torre Hernandez JM, Camarero T, Baz Alonso JA, Gomez Hospital J, Veiga Fernandez G, Lee Hwang D, Laso F, Sanchez Recalde A, Perez de Prado A, Lozano I, Hernandez Hernandez F, Gonzalez Lizarbe S, Gutierrez Alonso L, Zueco J, Alfonso F

February 4, 2020 | 10.4244/EIJ-D-19-01057

Coronary interventions

Stepwise visualization of a provisional bifurcation stenting procedure—multimodal visualization within a reanimated human heart utilizingVisible Heart® methodologies

Iles TL, Burzotta F, Lassen JF, Iaizzo P

January 21, 2020 | 10.4244/EIJ-D-19-00606

Coronary interventions

Impact of Bioresorbable Scaffold Design Characteristics on Local Hemodynamic Forces - an ex vivo Assessment with Computational Fluid Dynamics Simulations

Tarrahi I, Colombo M, Hartman EM, Tovar Forero MN, Torii R, Chiastra C, Daemen J, Gijsen F

January 21, 2020 | 10.4244/EIJ-D-19-00657

Coronary interventions

The obesity paradox revisited: body mass index and long-term outcomes after PCI from a large pooled patient-level database

Wolny R, Maehara A, Liu Y, Zhang Z, Mintz G, Redfors B, Madhavan M, Smits P, von Birgelen C, Serruys P, Mehran R, Leon M, Stone GW

January 17, 2020 | 10.4244/EIJ-D-19-00467

Coronary interventions

First-in-man randomised comparison of the Angiolite durable fluoroacrylate polymer-based sirolimus-eluting stent versus a durable fluoropolymer-based everolimus-eluting stent in patients with coronary artery disease: the ANGIOLITE trial

Moreu J, Moreno-Gómez R, Pérez de Prado A, García del Blanco B, Trillo R, Pinar E, Molina E, Zueco J, Merchán A, Díaz-Fernández J, Amat I

December 20, 2019 | 10.4244/EIJ-D-19-00206

Coronary interventions

Effect of rosuvastatin and eicosapentaenoic acid on neoatherosclerosis: the LINK-IT Trial

Kuroda K, Otake H, Shinohara M, Kuroda M, Tsuda S, Toba T, Nagano Y, Toh R, Ishida T, Shinke T, Hirata K

December 20, 2019 | 10.4244/EIJ-D-18-01073

Coronary interventions

Outcomes of stent optimisation in intravascular ultrasound-guided intervention for long or chronic totally occluded coronary lesions

Kim D, Hong S-J, Kim B-K, Shin D-H, Ahn C, Kim J-S, Ko Y-G, Choi D, Hong M-K, Jang Y

December 10, 2019 | 10.4244/EIJ-D-19-00762

Coronary interventions

BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12 months

Saito S, Toelg R, Witzenbichler B, Haude M, Masotti M, Salmeron R, Witkowski A, Uematsu M, Takahashi A, Waksman R, Slagboom T

December 6, 2019 | 10.4244/EIJ-D-18-01214

Coronary interventions

Ten-year outcomes from a randomised comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study

Pareek M, Madsen M, Warnakula Olesen K, Okkels Jensen L, Christiansen E, Dalby Kristensen S, Flensted Lassen J, Thuesen L, Bøtker H, Maeng M

December 6, 2019 | 10.4244/EIJ-D-19-00503

Coronary interventions

Procedural Characteristics and Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention for Left Main Trifurcation Disease: The EXCEL trial

Kandzari D, Gershlick A, Serruys P, Leon M, Morice M, Simonton C, Lembo N, Mansour S, Sabaté M, Sabik III JF, Kappetein AP, Dressler O, Stone GW

December 3, 2019 | 10.4244/EIJ-D-19-00686

Coronary interventions

Influence of Final Kissing Balloon Inflation on Long-term Outcomes After PCI of Distal Left Main Bifurcation Lesions: Analysis From the EXCEL Trial

Kini A, Dangas G, Baber U, Vengrenyuk Y, Kandzari D, Leon M, Morice M, Serruys P, Kappetein AP, Sabik III JF, Dressler O, Mehran R, Sharma SK, Stone GW

November 26, 2019 | 10.4244/EIJ-D-19-00851

Coronary interventions

Drug-coated Balloons for the Treatment of Coronary In-stent Restenosis: A Multicentre, Randomised Controlled Clinical Study

Hamm C, Dorr O, Wöhrle J, Krackhardt F, Ince H, Zeus T, Berland J, Piot C, Roubille F, Schult I, Allocco D, Nef H

November 20, 2019 | 10.4244/EIJ-D-19-00051

1
2
3
...
13

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke